Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_assertion type Assertion NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_head.
- NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_assertion description "[Interestingly, drugs used for other diseases, such as statins, Rho-kinase inhibitors, imatinib mesylate, may control the pathological vascular remodeling of PAH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_provenance.
- NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_assertion evidence source_evidence_literature NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_provenance.
- NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_assertion SIO_000772 17346158 NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_provenance.
- NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_assertion wasDerivedFrom befree-20150227 NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_provenance.
- NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_assertion wasGeneratedBy ECO_0000203 NP673983.RAJystHAXrqI0i6v_CUhcDrqXoMc516EU2mkdAVH3Gkc0130_provenance.